FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387009002: Temozolomide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461187010 Temozolomide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481123019 Temozolomide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
59361000195119 temozolomide it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
844111000172114 témozolomide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
74671000195116 Temozolomid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Temozolomide (substance) Is a Triazene antineoplastic (substance) true Inferred relationship Some
Temozolomide (substance) Is a Cytotoxic true Inferred relationship Some
Temozolomide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Alkylating agent (disposition) true Inferred relationship Some
Temozolomide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that destroys or impairs the function of living cells true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing temozolomide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some
Temozolomide 20 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some
Temozolomide 100 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some
Temozolomide 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some
Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some
Product containing precisely temozolomide 180 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some
Product containing precisely temozolomide 140 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some
Product containing precisely temozolomide 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 5 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Temozolomide (substance) Inferred relationship Some 1
Temozolomide 20 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some 1
Temozolomide 20 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Temozolomide (substance) Inferred relationship Some 1
Temozolomide 100 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some 1
Temozolomide 100 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Temozolomide (substance) Inferred relationship Some 1
Temozolomide 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some 1
Temozolomide 250 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 140 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 140 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 180 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 180 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 180 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Temozolomide (substance) Inferred relationship Some 1
Temozolomide 100 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Temozolomide (substance) Inferred relationship Some 1
Temozolomide 250 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Temozolomide (substance) Inferred relationship Some 1
Product containing temozolomide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 140 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 5 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Temozolomide (substance) Inferred relationship Some 1
Temozolomide 20 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Temozolomide (substance) Inferred relationship Some 1
Product containing only temozolomide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Temozolomide (substance) Inferred relationship Some 1
Product containing only temozolomide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Temozolomide (substance) Inferred relationship Some 1
Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Temozolomide (substance) Inferred relationship Some 1
Temozolomide-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Temozolomide (substance) Inferred relationship Some 1
Temozolomide only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Temozolomide (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

Back to Start